March 15, 2022 Today, Calibr and AbbVie announced a partnership to advance promising direct-acting antiviral compounds into clinical development for the treatment of COVID. This success is built on an intense 2-year effort to build up a BSL3 drug discovery workflow from scratch to support an astonishing medicinal chemistry effort to deliver a direct-acting antiviral in a relatively short period of time. With some good fortune, we hope to see the first compound advance into clinical trials in the near future.
December 20, 2021 We have a new addition! Brianna Lee, a very recent graduate of nearby San Diego State University, has joined Melissa's team and will be an integral member of the cryptosporidiosis drug discovery program. It's great to have an Aztec on our team.
June 3, 2021 Congratulations to Malina, Karen, Melanie, Laura and Kastin for their publication in Nature Communications! This manuscript captures the beginning of our collective efforts, in collaboration with Scripps Research, to discover new medicines to treat or prevent COVID-19. This work was primarily carried out in the BSL3/ABSL3 facilities and represents a phenomenal effort to develop an in vitro and in vivo workflow on a new virus in a matter of months. The effort, dedication and skill of everyone involved is unmatched and it has been my pleasure to be a part of the team.
June 2, 2021 Carolina has arrived! Her kinetoplastid experience will be put to great use as a member of Malina's team. Welcome!
April 19, 2021 Welcome Krittikorn! We're excited to have you join the malaria drug discovery team.
March 25, 2021 Congratulations to Kastin Pan, our long-time intern, for earning her Bachelors degree from UC, San Diego! Kastin is a hard-working, gifted researcher and wonderful human. We're excited for her to continue her development as a member of Malina's research team.
January 4, 2021 Kick-off of the 3-year grant from the Wellcome Trust which will fund Calibr to be a NTD Flagship in drug discovery for Dengue fever, schistosomiasis, cryptosporidiosis, leishmaniasis, and Chagas Disease.